Nestle branches out into skin care

JOHN HEILPRIN
Last updated 10:24 12/02/2014

Relevant offers

World

Amy Schumer calls for tighter gun control laws in the wake of Trainwreck theatre shooting President Obama heralds impact of US power plant greenhouse gas limits Greek stocks plunge 16pc as market reopens after debt crisis shutdown Greek debt crisis: The optimist's guide Rolling Stone editor quits as students sue Jack Dorsey's harsh criticism of Twitter's previous policies not enough to turn company around Facebook profit slides 9 per cent, heavy spending on investments US Fed leaves door open for rate hike in September VW beats Toyota as world's biggest automaker Trade ministers cautiously hopeful about Trans-Pacific Partnership deal

Swiss food and drink group Nestle is creating a new unit for medical skin treatments via a deal that reduces its stake in French cosmetics company L'Oreal.

The Vevey, Switzerland-based company said on Tuesday it would take full ownership of Swiss dermatology pharmaceuticals company Galderma, which had been a 50/50 joint venture with L'Oreal.

It will use Galderma's management to form a new unit called Nestle Skin Health SA.

Nestle is striving to reposition its food-and-beverage business more into the nutrition and wellness fields.

Galderma's business fits in that new mold.

"The future of skin health and dermatology is a buoyant market globally," Nestle chief executive Paul Bulcke said.

Galderma, a Swiss company created in 1981, sells products in 70 countries that treat skin diseases including acne, psoriasis and cancer. The deal is subject to regulatory approval.

As part of the complicated deal, which is valued at €6.5 billion ($10.7 billion), Nestle's stake in L'Oreal will fall from 29.4 per cent to 23.3 per cent.

L'Oreal will buy back €48.5 million of its own shares and then cancel them.

Nestle chairman Peter Brabeck-Letmathe said the deal did not mean the company was abandoning its involvement in L'Oreal.

"Nestle will continue to support the development of L'Oreal as in the past 40 years," he said.

Following the share buyback and cancellation, the Bettencourt Meyers family's stake in L'Oreal will increase from 30.6 per cent to 33.3 per cent.

Ad Feedback

- AP

Special offers

Featured Promotions

Sponsored Content